Search research articles
Contact Us
Filters
Showing results (61-70 of 257) with videos related to
Page
of 26
Sort By:
The Biochemical Journal
|
February 1, 1990
Subcellular distribution of alpha 2-adrenergic receptors, pertussis-toxin substrate and adenylate cyclase in human platelets
M A Zamorski, J C Ferraro, R R Neubig
Journal of Cardiovascular Pharmacology
|
January 1, 1985
Methods for measuring vascular and nonvascular alpha-receptor sensitivity in humans
B Egan, R Neubig, R H Schneider, et al.
Molecular Pharmacology
|
December 1, 1988
Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor
W J Thomsen, J A Jacquez, R R Neubig
Pharmacological Reviews
|
December 6, 2003
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology
Richard R Neubig, Michael Spedding, Terry Kenakin, et al.
Molecular Pharmacology
|
August 9, 2017
Human Missense Mutations in Regulator of G Protein Signaling 2 Affect the Protein Function Through Multiple Mechanisms
Hoa T N Phan, Benita Sjögren, Richard R Neubig
Life Sciences
|
February 24, 2001
Timing is everything the role of kinetics in G protein activation
L D Shea, R R Neubig, J J Linderman
Biochemistry
|
April 5, 1988
Mechanism of agonist and antagonist binding to alpha 2 adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex
R R Neubig, R D Gantzos, W J Thomsen
Biochemistry
|
July 6, 1982
Conformations of Torpedo acetylcholine receptor associated with ion transport and desensitization
R R Neubig, N D Boyd, J B Cohen
Molecular Pharmacology
|
November 1, 1985
Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry
R R Neubig, R D Gantzos, R S Brasier
Frontiers in Immunology
|
April 9, 2021
COVID-19-A Theory of Autoimmunity Against ACE-2 Explained
Philip McMillan, Thomas Dexhiemer, Richard R Neubig, et al.
Page
of 26
Search research articles
Search
Showing results (61-70 of 257) with videos related to
Sort By:
Page
of 26
The Biochemical Journal
|
February 1, 1990
Subcellular distribution of alpha 2-adrenergic receptors, pertussis-toxin substrate and adenylate cyclase in human platelets
M A Zamorski, J C Ferraro, R R Neubig
Journal of Cardiovascular Pharmacology
|
January 1, 1985
Methods for measuring vascular and nonvascular alpha-receptor sensitivity in humans
B Egan, R Neubig, R H Schneider, et al.
Molecular Pharmacology
|
December 1, 1988
Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor
W J Thomsen, J A Jacquez, R R Neubig
Pharmacological Reviews
|
December 6, 2003
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology
Richard R Neubig, Michael Spedding, Terry Kenakin, et al.
Molecular Pharmacology
|
August 9, 2017
Human Missense Mutations in Regulator of G Protein Signaling 2 Affect the Protein Function Through Multiple Mechanisms
Hoa T N Phan, Benita Sjögren, Richard R Neubig
Life Sciences
|
February 24, 2001
Timing is everything the role of kinetics in G protein activation
L D Shea, R R Neubig, J J Linderman
Biochemistry
|
April 5, 1988
Mechanism of agonist and antagonist binding to alpha 2 adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex
R R Neubig, R D Gantzos, W J Thomsen
Biochemistry
|
July 6, 1982
Conformations of Torpedo acetylcholine receptor associated with ion transport and desensitization
R R Neubig, N D Boyd, J B Cohen
Molecular Pharmacology
|
November 1, 1985
Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry
R R Neubig, R D Gantzos, R S Brasier
Frontiers in Immunology
|
April 9, 2021
COVID-19-A Theory of Autoimmunity Against ACE-2 Explained
Philip McMillan, Thomas Dexhiemer, Richard R Neubig, et al.
Page
of 26